Progenics Pharma (PGNX) Reports In-Line Q4 Loss
Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) reported Q4 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)